ArticleBMJ open ophthalmology2026
Role of systemic hypoxia in the progression of diabetic retinopathy: a propensity-matched retrospective cohort study.
Article in BMJ open ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
objectiveThis study aims to assess the association between systemic hypoxia and progression from non-proliferative diabetic retinopathy (NPDR) to proliferative diabetic retinopathy (PDR) and vision-threatening outcomes. METHODS AND ANALYSIS: This retrospective cohort study used the TriNetX Network to identify adults with NPDR with no prior PDR. Systemic hypoxia was defined using International Classification of Diseases 10th revision (ICD-10) codes for anaemia, obstructive sleep apnoea, chronic respiratory failure, chronic obstructive pulmonary disease, pulmonary hypertension or interstitial lung disease. Both cohorts were propensity score-matched. The primary outcome was progression to PDR. Secondary outcomes included vitreous haemorrhage, tractional retinal detachment, legal blindness, diabetic macular oedema and therapeutic interventions. Time-to-event analyses were performed using Cox proportional hazards models, and 5-year cumulative incidence was assessed using Kaplan-Meier analysis.
resultsAfter matching, 92 454 patients were included in each cohort with well-balanced baseline characteristics (all standardised mean differences <0.1). Systemic hypoxia was associated with increased risk of PDR progression (HR 1.24; 95% CI 1.18 to 1.31; p<0.001). 5-year cumulative PDR incidence was higher in the hypoxia cohort (4.2% vs 2.6%; risk ratio 1.63). Patients with systemic hypoxia also had higher risks of vitreous haemorrhage, tractional retinal detachment, blindness and increased utilisation of panretinal photocoagulation and pars plana vitrectomy. Subgroup analyses identified anaemia as the primary driver of PDR progression, whereas respiratory aetiologies were not independently associated after matching.
conclusionsSystemic hypoxia, a diagnosis-code-based composite in which anaemia-associated phenotypes showed the strongest association, is associated with accelerated PDR progression and near-doubled legal blindness risk. Anaemia screening may offer an opportunity to reduce vision-threatening complications in diabetic patients. These findings are hypothesis-generating and warrant prospective validation before informing screening pathways, given the retrospective design and absence of measured oxygen saturation, haemoglobin and glycaemic data.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.